MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • MDS Virtual Congress 2020

    Frequency of Nonmotor Symptoms Parkinson’s Disease in the Early Morning off Period

    Y.L Keceli, A.S Tokcaer (Ankara, Turkey)

    Objective: To increase early recognition of these symptoms, by investigating the frequency of nonmotor symptoms (NMS) in patients with Parkinson's disease (PD) who have early…
  • MDS Virtual Congress 2020

    Prevalence of dysphagia and screening tools in patients with Parkinson’s disease

    H. Téllez-Lucero, O. Cárdenaz-Saenz, F. Herrera-Rodríguez, E. Escobar-Valdivia, A. Abundes-Corona, O. Esquivel-Zapata, Y. Ríos-Solís, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: Determine the prevalence of dysphagia in patients with Parkinson's disease (PD) and compare the Swallowing Disturbance Questionnaire (SDQ) and Eating Assessment Tool (EAT-10). Background:…
  • MDS Virtual Congress 2020

    Quantifying the incremental burden of advancing Parkinson’s disease in patients meeting the “5-2-1” Criteria: Results from an international dataset from G7 countries

    I. Malaty, M. Skorvanek, A. Alobaidi, K. Onuk, L. Bergmann, S. Femia, M. Lee, E. Jones, J. Pike, P. Martinez-Martin (Gainesville, FL, USA)

    Objective: Quantify the incremental clinical and humanistic burden of advancing Parkinson’s disease (PD) in patients meeting the “5-2-1” criteria. Background: The burden of PD worsens…
  • MDS Virtual Congress 2020

    What can tell us Non-Motor Symptoms about Cognition and Gait in the Early Stage of PD Patients

    B. Munoz Ospina, V. Quintana-Peña, D. Rincón, J. Valderrama, Y. Castaño-Pino, J. Orozco Velez, A. Navarro (Cali, Colombia)

    Objective: To describe the motor, cognitive and non-motor profiles in the early stage of PD using eMotion Kinect system, Moca Test and PD-CRS. Background: The…
  • MDS Virtual Congress 2020

    Effect of regular practice of yoga versus aerobic exercise on motor and non motor signs and motor cortex plasticity in Parkinson’s disease

    A. Kishore, P. James, A. Thejaus, S. Krishnan, K. Divya, S. Meunier (Trivandrum, India)

    Objective: To test whether the regular practice of yoga (1) improves motor and non-motor symptoms and signs in Parkinson’s disease (PD) more than aerobic training…
  • MDS Virtual Congress 2020

    Urinary Symptoms and Parkinson’s Disease: The Patient’s Perspective

    J. Wertheimer, B. Reynolds, C. Walton, J. McNamara, T. Hamran, S. Freedland (Los Angeles, CA, USA)

    Objective: To learn about prevalence rates and the impact of urinary symptoms on day-to-day function and quality of life from the patient’s perspective. Background: Urinary…
  • MDS Virtual Congress 2020

    Cognitive pretesting of the Functional Rating Scale 2.0 for Huntington’s disease (FuRST 2.0): An iterative process

    P. Feigenbaum, R. Fuller, N. Lapelle, C. Fitzer-Attas, S. Luo, B. Tilley, M. Guttman, C. Goetz, C. Sampaio, G. Stebbins (Princeton, NJ, USA)

    Objective: Develop a functional rating scale for Huntington’s disease (HD) using iterative rounds of cognitive pretesting (CPT). Background: We previously reported on focus group and…
  • MDS Virtual Congress 2020

    Increased neurofilament light chain plasma levels as a biological marker of mild cognitive impairment in Parkinson’s disease

    J. Pagonabarraga, R. Perez-Gonzalez, H. Bejr-Kasem, J. Marin-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, F. Sampedro, S. Martinez-Horta, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To examine whether PD-MCI patients have increased plasma neurofilament light chain (NfL) levels compared to PD with normal cognition (PD-NC) and healthy controls (HC).…
  • MDS Virtual Congress 2020

    Non-Motor Fluctuations in Parkinson’s Disease (PD): Development and Validation of the Non-Motor Fluctuation Assessment Instrument (NoMoFA)

    G. Kleiner, H. Fernandez, K. Chou, A. Fasano, K. Duque, D. Hengartner, A. Law, A. Margolius, Y. Poon, M. Saenz-Farret, P. Saleh, J. Vizcarra, G. Stebbins, A. Espay (Toronto, ON, Canada)

    Objective: Validate and demonstrate reliability of the NoMoFA. Background: In patients with PD, sleep, mood, cognitive, autonomic and other non-motor symptoms (NMS) may fluctuate (NMF)…
  • MDS Virtual Congress 2020

    Dry Eye and Parkinson’s Disease: A Literature Review

    S. Yaisawang, N. Kasetsuwan, U. Reinprayoon, J. Sringean, R. Bhidayasiri, K. Pongpirul (Bangkok, Thailand)

    Objective: To emphasize the dry eye diseases in Parkinson’s disease patients Background: In a patient with dry eye, ocular surface could have local inflammation and…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley